Protagenic Therapeutics, Inc.\new
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $1.1M | $8.0M | — |
| FY2023 | $655.3K | $4.3M | — |
| FY2024 | $942.8K | $2.0M | $1.6K |
| FY2025 | $5.0M | $89.1K | $14.5K |
| FY2026 | $1.0M | $3.7M | $1.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $1.1M | $8.0M | — |
| FY2023 | $655.3K | $4.3M | — |
| FY2024 | $942.8K | $2.0M | $1.6K |
| FY2025 | $5.0M | $89.1K | $14.5K |
| FY2026 | $1.0M | $3.7M | $1.5M |